1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow CAEBV: new trials by email Literature Review of CAEBV trials Research Report on CAEBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golidocitinib Combined With Selinexor for CAEBVD golidocitinib, Selinexor (combination therapy) - Lymphohistiocytosis, EBV | Phase 2 / Phase 3 | Recruiting | Beijing Friendship Hospital | 28 | 2026-01-01 | 2026-01-27 |
| Sintilimab and Lenalidomide as a Treatment for CAEBV Sintilimab and lenalidomide, Sintilimab placebo and lenalidomide placebo - CAEBV | Phase 2 | Unknown | Zhao Wang | 51 | 2020-08-01 | 2020-08-19 |
Combined Modality Therapy (1) · Lenalidomide (1) · selinexor (1) · sintilimab (1)
Beijing Friendship Hospital (1) · Zhao Wang (1)
China (2)